Abstract |
The administration of reference endotoxin (Escherichia coli O:113, Lot EC-5) to humans has been an important means to study inflammation in vivo; however, the supply of Lot EC-5 is depleted. A new lot of reference endotoxin (Clinical Center reference endotoxin [CCRE]), derived from the original bulk material extracted from E. coli O:113, was processed. The effects of 0-, 1-, 2-, and 4-ng/kg doses of intravenous CCRE and EC-5 were studied in 20 male subjects. CCRE resulted in dose-related increases in symptoms, temperature (P=. 016), total leukocyte count (P=.014), tumor necrosis factor-alpha (P=.004), interleukin (IL)-1 receptor antagonist (P=.004), IL-6 (P=. 005), IL-8 (P=.011), cortisol (P<.05), and C-reactive protein (P=. 04). These responses were attenuated (all P<.012) in subjects given Lot EC-5 (4 ng/kg) in comparison with those in subjects given CCRE, showing that, over several years, EC-5 had lost potency. Thus, in healthy subjects, the magnitude of exposure to CCRE results in a graded dose response of major components of innate immunity.
|
Authors | A F Suffredini, H D Hochstein, F G McMahon |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 179
Issue 5
Pg. 1278-82
(May 1999)
ISSN: 0022-1899 [Print] United States |
PMID | 10191237
(Publication Type: Journal Article)
|
Chemical References |
- Cytokines
- Endotoxins
- endotoxin, Escherichia coli
- Hydrocortisone
|
Topics |
- Adult
- Cytokines
(blood)
- Dose-Response Relationship, Drug
- Endotoxins
(administration & dosage, toxicity)
- Evaluation Studies as Topic
- Humans
- Hydrocortisone
(blood)
- Inflammation
(immunology, pathology)
- Injections, Intravenous
- Leukocyte Count
- Male
- Middle Aged
- National Institutes of Health (U.S.)
- Reference Standards
- United States
|